Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 10
Submit an article Journal homepage
777
Views
37
CrossRef citations to date
0
Altmetric
Review

Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?

Vasilios G AthyrosAristotle University of Thessaloniki, Hippocration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece+30 2310 892606; +30 2310 835955; [email protected]
,
Niki KatsikiAristotle University of Thessaloniki, Hippocration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece+30 2310 892606; +30 2310 835955; [email protected]
,
Asterios KaragiannisAristotle University of Thessaloniki, Hippocration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece+30 2310 892606; +30 2310 835955; [email protected]
&
Dimitri P MikhailidisUniversity College London Medical School, Department of Clinical Biochemistry (Vascular Prevention Clinic), Royal Free Campus, London, UK
Pages 1449-1461 | Published online: 03 Jun 2015

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Aneth Telesphore Bideberi & Reuben Mutagaywa. (2022) Statin Prescription Patterns and Associated Factors Among Patients with Type 2 Diabetes Mellitus Attending Diabetic Clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Diabetes, Metabolic Syndrome and Obesity 15, pages 633-646.
Read now
Niki Katsiki & Vasilios G Athyros. (2019) Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment. Current Medical Research and Opinion 35:7, pages 1305-1306.
Read now
Niki Katsiki, Genovefa Kolovou, Pablo Perez-Martinez & Dimitri P. Mikhailidis. (2018) Dyslipidaemia in the elderly: to treat or not to treat?. Expert Review of Clinical Pharmacology 11:3, pages 259-278.
Read now
Melissa Rothfus, Ingrid S. Sketris, Robyn Traynor, Melissa Helwig & Samuel A. Stewart. (2016) Measuring Knowledge Translation Uptake Using Citation Metrics: A Case Study of a Pan-Canadian Network of Pharmacoepidemiology Researchers. Science & Technology Libraries 35:3, pages 228-240.
Read now

Articles from other publishers (32)

Lise Tuset Gustad, Anna Marie Holand, Torfinn Hynnekleiv, Ottar Bjerkeset, Michael Berk & Solfrid Romundstad. (2022) The bidirectional association between depressive symptoms, assessed by the HADS, and albuminuria–A longitudinal population-based cohort study with repeated measures from the HUNT2 and HUNT3 Study. PLOS ONE 17:9, pages e0274271.
Crossref
Jiayi Xiang, Huifang Zhang, Xingcheng Zhou, Dan Wang, Rongyu Chen, Wanlin Tan, Luqun Liang, Mingjun Shi, Fan Zhang, Ying Xiao, Yuxia Zhou, Yuanyuan Wang & Bing Guo. (2022) Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression. Frontiers in Pharmacology 13.
Crossref
Juliette Raffort, Fabien Lareyre, Niki Katsiki & Dimitri P. Mikhailidis. (2022) Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 1. Current Vascular Pharmacology 20:1, pages 3-15.
Crossref
Zoi Kleinaki, Aris P Agouridis, Maria Zafeiri, Theodoros Xanthos & Constantinos Tsioutis. (2020) Epicardial adipose tissue deposition in patients with diabetes and renal impairment: Analysis of the literature. World Journal of Diabetes 11:2, pages 33-41.
Crossref
Vasilios Papademetriou, Sofia Alataki, Konstantinos Stavropoulos, Christodoulos Papadopoulos, Kostas Bakogiannis & Kostas Tsioufis. (2020) Pharmacological Management of Diabetic Nephropathy. Current Vascular Pharmacology 18:2, pages 139-147.
Crossref
Luca Zanoli, Paolo Lentini, Marie Briet, Pietro Castellino, Andrew A. House, Gerard M. London, Lorenzo Malatino, Peter A. McCullough, Dimitri P. Mikhailidis & Pierre Boutouyrie. (2019) Arterial Stiffness in the Heart Disease of CKD. Journal of the American Society of Nephrology 30:6, pages 918-928.
Crossref
Mohsen Mazidi, Niki Katsiki, Dimitri P. Mikhailidis & Maciej Banach. (2018) A higher ratio of refined grain to whole grain is associated with a greater likelihood of chronic kidney disease: a population-based study. British Journal of Nutrition 121:11, pages 1294-1302.
Crossref
Diego Francisco Márquez, Gema Ruiz-Hurtado, Julian Segura & Luis Ruilope. (2019) Microalbuminuria and cardiorenal risk: old and new evidence in different populations. F1000Research 8, pages 1659.
Crossref
Niki Katsiki & Dimitri P Mikhailidis. (2018) Lipids: a personal view of the past decade. Hormones 17:4, pages 461-478.
Crossref
Andrie G. Panayiotou, Panayiotis Kouis & Andreas Kousios. (2018) Matrix Metalloproteinases as Markers of Atherosclerosis in Renal Patients: Are we there Yet?. Current Vascular Pharmacology 17:1, pages 50-51.
Crossref
Min Liu, Zhi-Hui Yang & Guo-Hui Li. (2018) A Novel Method for the Determination of Vancomycin in Serum by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Application in Patients with Diabetic Foot Infections. Molecules 23:11, pages 2939.
Crossref
Niki Katsiki, Vivian Fonseca & Dimitri P. Mikhailidis. (2018) Contrast-induced acute kidney injury in diabetes mellitus: Clinical relevance and predisposing factors. Could statins be of benefit?. Journal of Diabetes and its Complications 32:11, pages 982-984.
Crossref
Niki Katsiki, Filippos Triposkiadis, Athanasios D. Giannoukas & Dimitri P. Mikhailidis. (2018) Statin loading in cardiovascular surgery. Current Opinion in Cardiology 33:4, pages 436-443.
Crossref
Kosuke Sawami, Atsushi Tanaka, Tsukasa Nakamura, Eiichi Sato, Yoshihiko Ueda & Koichi Node. (2018) Multiple potency of ezetimibe in a patient with macroproteinuric chronic kidney disease and statin-intolerant dyslipidemia. Journal of Cardiology Cases 17:6, pages 204-207.
Crossref
Niki Katsiki, Athanasios D Giannoukas, Vasilios G Athyros & Dimitri P Mikhailidis. (2018) Lipid-lowering treatment in peripheral artery disease. Current Opinion in Pharmacology 39, pages 19-26.
Crossref
Xinmiao Zhang, Jing Jing, Xingquan Zhao, Liping Liu, Chunxue Wang, Yuesong Pan, Xia Meng, Yilong Wang & Yongjun Wang. (2018) Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease. European Neurology 79:5-6, pages 296-302.
Crossref
Xi-Bei JiaXi-Hua HouQiu-Bo MaXiao-Wen Cai, Yi-Ran Li, Su-Hong Mu, Shi-Ping Na, Ru-Juan Xie & Yu-Shi Bao. (2017) Assessment of Renal Function and Risk Factors for Chronic Kidney Disease in Patients With Peripheral Arterial Disease. Angiology 68:9, pages 776-781.
Crossref
Kosmas I. Paraskevas & Dimitri P. Mikhailidis. (2016) Contrast-Induced Acute Kidney Injury in Patients Undergoing Carotid Artery Stenting: An Underestimated Issue. Angiology 68:9, pages 752-756.
Crossref
Xiao-Sheng Guo, Kai-Yang Lin, Hua-Long Li, Ji-Yan Chen, Ying-Ling Zhou, Yong Liu, Ning Tan, Emily R Atkins, Peng Ran, Jun-Qing Yang, Deng-Xuan Wu, Shi-Qun Chen, Chong-Yang Duan & Ping-Yan Chen. (2016) Preprocedural High-Sensitivity C-Reactive Protein Predicts Contrast-Induced Nephropathy and Long-Term Outcome After Coronary Angiography. Angiology 68:7, pages 614-620.
Crossref
Ingrid Platania, Valentina Terranova, Salvatore Davide Tomasello, Marouane Boukhris, Chiara Cilia, Salvatore Di Marca, Marcella Pisano, Gianluca Mastrosimone, Emanuela Cataudella, Benedetta Stancanelli & Lorenzo Malatino. (2016) Mean Transaortic Gradient is an Emerging Predictor of Chronic Kidney Disease in Elderly Patients. Angiology 68:6, pages 528-534.
Crossref
Eun Yeong Cho, Chana Myoung, Hong-suk Park, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung & Ji Yong Jung. (2017) Efficacy of Statin Treatment in Early-Stage Chronic Kidney Disease. PLOS ONE 12:1, pages e0170017.
Crossref
Amirhossein Sahebkar, Renato Giua & Claudio Pedone. (2016) Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. British Journal of Clinical Pharmacology 82:6, pages 1674-1684.
Crossref
Gema Ruiz-Hurtado, Pantelis Sarafidis, María S. Fernández-Alfonso, Bernard Waeber & Luis M. Ruilope. (2016) Global cardiovascular protection in chronic kidney disease. Nature Reviews Cardiology 13:10, pages 603-608.
Crossref
Vasilios G. Athyros, Niki Katsiki & Dimitri P. Mikhailidis. (2016) Statins, renal function and homocysteine. Pharmacological Reports 68:5, pages 1093.
Crossref
Jonathan Wagner & Susan M. Abdel-Rahman. (2016) Pediatric Statin Administration: Navigating a Frontier with Limited Data. The Journal of Pediatric Pharmacology and Therapeutics 21:5, pages 380-403.
Crossref
Stein I. Hallan, Marius A. Øvrehus, Solfrid Romundstad, Dena Rifkin, Arnulf Langhammer, Paul E. Stevens & Joachim H. Ix. (2016) Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway. Kidney International 90:3, pages 665-673.
Crossref
Fabio Fabbian, Alfredo De Giorgi, Fabio Manfredini, Nicola Lamberti, Silvia Forcellini, Alda Storari, Paola Todeschini, Massimo Gallerani, Gaetano La Manna, Dimitri P. Mikhailidis & Roberto Manfredini. (2016) Impact of comorbidity on outcome in kidney transplant recipients: a retrospective study in Italy. Internal and Emergency Medicine 11:6, pages 825-832.
Crossref
Niki Katsiki, Dimitri P. Mikhailidis & Christos S. Mantzoros. (2016) Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 65:8, pages 1109-1123.
Crossref
Dong-hyun Kim, Bo-hyun Choi, Sae-Kwang Ku, Jeong-hyeon Park, Euichaul Oh & Mi-Kyoung Kwak. (2016) Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice. PLOS ONE 11:4, pages e0153965.
Crossref
Vasilios G. Athyros & Dimitri P. Mikhailidis. (2016) High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practice. Journal of Diabetes and its Complications 30:1, pages 9-11.
Crossref
Vasilios G. Athyros, Konstantinos Tziomalos & Asterios Karagiannis. (2016) Statins for Improving Myocardial Perfusion in Patients With Nonalcoholic Fatty Liver Disease Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology 117:2, pages 311-312.
Crossref
Niki Katsiki, Vasilios G. Athyros & Dimitris P. Mikhailidis. (2016) More news from IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial). Hormones 15:1, pages 5-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.